Cowen initiates coverage on Madrigal Pharmaceuticals (NASDAQ: MDGL) with a Outperform rating.Analyst Ritu Baral comments "We see December ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE